Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Explore the fundamental principles of financial planning that guide effective money management and help you achieve your financial objectives.
17,965 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Gold soars to $5,100 an ounce as major indices retreat and oil prices climb, signaling a shift toward hedges and new ...
An Ohio judge denied Kalshi’s request for an injunction against state gaming authorities, keeping the platform’s chal...
As XRP trades near $1.43, analysts weigh whether a $10 price is possible and outline the five catalysts and macro con...
Oil prices rose above $100 a barrel after a large emergency stockpile release. Yet investor fears lingered about supp...
Two sentences: The oscars’ best picture category doubles as a market signal this year. Production data show shoots mo...
Could XRP slip below $2 by 2027? This guide breaks down the three big hurdles, explains why a lower price is plausibl...
Energy Transfer sits at the heart of U.S. energy infrastructure. This guide explains when energy transfer stock right...
Dreaming of a portfolio that compounds for decades? This article lays out three growth stocks hold forever that pass ...
Two powerhouse energy stocks could shape the next decade. This guide explains why NextEra Energy and GE Vernova fit a...
The Federal Reserve decided to keep rates unchanged, citing resilient growth and persistent price pressures. Geopolit...
A new deduction for interest on auto loans for 2025 buyers could cut tax bills even for standard-deduction filers. Bu...